Clinical and neuroimaging heterogeneity of dementia with Lewy bodies

Chimagomedova A.Sh.; Zorina N.A.; Arablinskiĭ A.V.; Levin O.S.

doi:https://doi.org/10.17116/jnevro201911909225

Close metadata

Recommended articles:

International multicenter randomized double-blind placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO): subanalysis in patients with arterial hypertension. Russian Journal of Preventive Medicine. 2024;(10):72-83

Resolution of the expert council «Possibilities of neuroprotective therapy in patients with arterial hypertension and cognitive disorders». Russian Journal of Preventive Medicine. 2024;(11):85-93

Cognitive impairment in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):81-90

Comorbidity of depression and dementia: epidemiological, biological and therapeutic aspects. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):113-121

Differentiated approach to cognitive rehabilitation of patients after stroke. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6):5-11

Activation of endogenous mechanisms of sanogenesis in cognitive impairment in cerebral small vessel disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):7-13

Cognitive impairment in bilinguals with neurological diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):26-29

Modern aspects of chronic cerebral ischemia pathogenetic therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):106-113

Comorbid anxiety disorders in patients with neurological pathology: current state of the problem and the role of etifoxine in treatment strategy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):126-136

The relationship between neuropsychological indicators and neuroimaging changes according to MRI morphometry in patients with Alzheimer’s disease and glaucoma. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):142-152

Abstract:

Objective. To study clinical characteristics of dementia with Lewy bodies (DLB) depending on neuropsychological, neuroimaging and concomitant cerebrovascular changes as well as on the character of disease onset. Material and methods. Forty-five patients with DLB (25 men and 20 women, men age 72.9±7.2 years, illness duration 2.9±2.2) were studied. The diagnosis was made according to international criteria (McKeith, et al, 2017). MRI, clinical/neurological examination and psychometric scales were used. Results and conclusion. Clinical, neuropsychological and neuroimaging results reveal the heterogeneity of DLB, which remains poorly investigated. An analysis of the clinical picture, cognitive profile, neuropsychiatric changes and MRI results identified three subtypes of DLB course: 1) typical; 2) with early psychotic manifestation; 3) atypical (mixed). This approach may improve the diagnosis of DLB, prognosis of disease course and treatment effectiveness.

Keywords:

dementia with Lewy bodies

cognitive impairment

dementia

neurodegenerative diseases

Authors:

Chimagomedova A.Sh.

Russian Medical Academy of Postgraduate Education, Moscow, Russia

Zorina N.A.

Botkin City Clinical Hospital, Moscow, Russia

Arablinskiĭ A.V.

Otdel luchevoĭ diagnostiki gorodskoĭ klinicheskoĭ bol'nitsy im. S.P. Botkina, Moskva

Levin O.S.

Rossiĭskaia meditsinskaia akademiia poslediplomnogo obrazovaniia

SPIN RSCI: 5342-1373
Scopus AuthorID: 57147160800
ORCID: 0000-0003-3872-5923

Close metadata

References:

Levin OS, Vasenina EE, Anikina MA, Makotrova TA. Dementia with Lewy bodies. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2012;112(10-2):3-12. (In Russ.)
Vann Jones S, O’Brien J. The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychol Med. 2014;44(4):673-683. https://doi.org/10.1017/S0033291713000494
McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O’Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017;89(1):88-100. https://doi.org/10.1212/WNL.0000000000004058
McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M; Consortium on DLB. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65(12):1863-1872. https://doi.org/10.1212/01.wnl.0000187889.17253.b1
Nelson PT, Jicha GA, Kryscio RJ, Abner EL, Schmitt FA, Cooper G, Xu LO, Smith CD, Markesbery WR. Low sensitivity in clinical diagnoses of dementia with Lewy bodies. J Neurol. 2010;257(3):359-366. https://doi.org/10.1007/s00415-009-5324-y
Collerton D, Burn D, McKeith I, O’Brien J. Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia. Dement Geriatr Cogn Disord. 2003;16(4):229-237.
Noe E, Marder K, Bell KL, Jacobs DM, Manly JJ, Stern Y. Comparison of dementia with Lewy bodies to Alzheimer’s disease and Parkinson’s disease with dementia. Mov Disord. 2004;19(1):60-67. https://doi.org/10.1002/mds.10633
Sarro L, Tosakulwong N, Schwarz CG, Graff-Radford J, Przybelski SA, Lesnick TG, Zuk SM, Reid RI, Raman MR, Boeve BF, Ferman TJ, Knopman DS, Comi G, Filippi M, Murray ME, Parisi JE, Dickson DW, Petersen RC, Jack CR Jr, Kantarci K. An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer’s disease. Alzheimers Dement. 2017;13(3):257-266. https://doi.org/10.1016/j.jalz.2016.07.003
Joki H, Higashiyama Y, Nakae Y, Kugimoto C, Doi H, Kimura K, Kishida H, Ueda N, Nakano T, Takahashi T, Koyano S, Takeuchi H, Tanaka F. White matterhyperintensities on MRI in dementia with Lewy bodies, Parkinson’s disease with dementia, and Alzheimer’s disease. J Neurol Sci. 2018;385:99-104. https://doi.org/10.1016/j.jns.2017.12.018
Ghebremedhin E, Rosenberger A, Rüb U, Vuksic M, Berhe T, Bickeböller H, de Vos RA, Thal DR, Deller T. Inverse relationship between cerebrovascular lesions and severity of lewy body pathology in patients with Lewy body diseases. J Neuropathol Exp Neurol. 2010;69:442-448. https://doi.org/10.1097/NEN.0b013e3181d88e63
Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR. The Addenbrooke’s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry. 2006;21(11):1078-1085. https://doi.org/10.1002/gps.1610
Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society. 2005;53(4):695-699.
Gutorova DA, Vasenina EE, LevinOS. Screening of cognitive impairment in the old and old-old population with the 3-CT scale. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2016;116(6):35-40. (In Russ.)
Harrison J, Buxton P, Husain M, Wise R. Short test of semantic and phonological fluency: Normal performance, validity and test-retest reliability. British Journal of Clinical Psychology. 2000;39(2):181-191. https://doi.org/10.1348/014466500163202
Lehfeld H, Erzigkeit H. The SKT — A Short Cognitive Performance Test for Assessing Deficits of Memory and Attention. Int Psychogeriatr. 1997;9(1):115-121.
Shulman K, Pushkar Gold D, Cohen C, Zucchero C. Clock-drawing and dementia in the community: A Longitudinal Study. Int J Geriat Psychiatry. 1993;8(6):487-496. https://doi.org/10.1002/gps.930080606
Jorm AF. The Informant Questionnaire on cognitive decline in the elderly (IQCODE): a review. Int Psychogeriatr. 2004;16(3):275-293.
Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell Scale For Depression in Dementia. Biological Psychiatry. 1988;23:271-284.
Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG. Reliability, validity, and clinical correlates of apathy in Parkinson’s disease. Journal of Neuropsychiatry. 1992;4:134-139.
Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308-2314.
Papapetropoulos S, Katzen H, Schrag A, Singer C, Scanlon BK, Nation D, Guevara A, Levin B. A questionnaire-based (UM-PDHQ) study of hallucinations in Parkinson’s disease. BMC Neurol. 2008;8:21. https://doi.org/10.1186/1471-2377-8-21
Abe K, Fujita M, Yoshikawa H. Movement Disorder Society Task Force on Rating Scales for Parkinson’s Disease. The Unified Parkinson’s Disease Rating Scale (UPDRS): status and recommendations. Mov Disord. 2003;18(7):738-750. https://doi.org/10.1002/mds.10473
Mahoney FI, Barthel DW. Functional Evaluation: the Barthel Index. Md State Med J. 1965;14:61-65.
Gibbons CH, Schmidt P, Biaggioni I, Frazier-Mills C, Freeman R, Isaacson S, Karabin B, Kuritzky L, Lew M, Low P, Mehdirad A, Raj SR, Vernino S, Kaufmann H. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol. 2017;264(8):1567-1582. https://doi.org/10.1007/s00415-016-8375-x
Postuma RB, Arnulf I, Hogl B, Iranzo A, Miyamoto T, Dauvilliers Y, Oertel W, Ju YE, Puligheddu M, Jennum P, Pelletier A, Wolfson C, Leu-Semenescu S, Frauscher B, Miyamoto M, Cochen De Cock V, Unger MM, Stiasny-Kolster K, Fantini ML, Montplaisir JY. A Single-Question Screen for REM Sleep Behavior Disorder: A Multicenter Validation Study. Mov Disord. 2012;27(7):913-916. https://doi.org/10.1002/mds.25037
Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540-545.
Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, Radner H, Lechner H. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993;43:1683-1689.
Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjögren M, Wallin A, Ader H, Leys D, Pantoni L, Pasquier F, Erkinjuntti T, Scheltens P; European Task Force on Age-Related White Matter Changes. A new rating scale for age-related white matter changes. Stroke. 2001;32(6):1318-1322.
Scheltens P, Launer LJ, Barkhof F, Weinstein HC, van Gool WA. Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability. J Neurol. 1995;242:557-560.
Morris JC. Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43:2412-2414.
Peavy GM, Edland SD, Toole BM, Hansen LA, Galasko DR, Mayo AM. Phenotypic differences based on staging of Alzheimer’s neuropathology in autopsy-confirmed dementia with Lewy bodies. Parkinsonism Relat Disord. 2016;31:72-78. https://doi.org/10.1016/j.parkreldis.2016.07.008
Elder GJ, Mactier K, Colloby SJ, Watson R, Blamire AM, O’Brien JT, Taylor JP. The influence of hippocampal atrophy on the cognitive phenotype of dementia with Lewy bodies. Int J Geriatr Psychiatry. 2017;32(11):1182-1189. https://doi.org/10.1002/gps.4719
Howlett DR, Whitfield D, Johnson M, Attems J, O’Brien JT, Aarsland D, Lai MK, Lee JH, Chen C, Ballard C, Hortobágyi T, Francis PT. Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias. Brain Pathol. 2015;25(4):401-408. https://doi.org/10.1111/bpa.12182
Chan PC, Wei CY, Hung GU, Chiu PY. Reduced vascular risk factors in Parkinson’s disease dementia and dementia with Lewy bodies compared to Alzheimer’s disease. Brain Behav. 2018;8(3):e00916. https://doi.org/10.1002/brb3.916
McKeith I, Taylor J, Thomas A, Donaghy P, Kane J. Revisiting DLB Diagnosis: A Consideration of Prodromal DLB and of the Diagnostic Overlap with Alzheimer Disease. Journal of Geriatric Psychiatryand Neurology.2016;29(5):249-253. https://doi.org/10.1177/0891988716656083
Blanc F, Mahmoudi R, Jonveaux T, Galmiche J, Chopard G, Cretin B, Demuynck C, Martin-Hunyadi C, Philippi N, Sellal F, Michel JM, Tio G, Stackfleth M, Vandel P, Magnin E, Novella JL, Kaltenbach G, Benetos A, Sauleau EA. Long-term cognitive outcome of Alzheimer’s disease and dementia with Lewy bodies: dual disease is worse. Alzheimers Res Ther. 2017;9(1):47. https://doi.org/10.1186/s13195-017-0272-8
Hanyu H, Sato T, Hirao K, Kanetaka H, Sakurai H, Iwamoto T. Differences in clinical course between dementia with Lewy bodies and Alzheimer’s disease. Eur J Neurol. 2009;16(2):212-217. https://doi.org/10.1111/j.1468-1331.2008.02388.x
Brenowitz WD, Hubbard RA, Keene CD, Hawes SE, Longstreth WT, Woltjer RL, Kukull WA. Mixed neuropathologies and estimated rates of clinical progression in a large autopsy sample. Alzheimers Dement. 2017;13(6):654-662. https://doi.org/10.1016/j.jalz.2016.09.015
Rongve A, Soennesyn H, Skogseth R, Oesterhus R, Hortobágyi T, Ballard C, Auestad BH, Aarsland D. Cognitive decline in dementia with Lewy bodies: a 5-year prospective cohort study. BMJ Open. 2016;6(2):e010357. https://doi.org/10.1136/bmjopen-2015-010357
Vasenina EE. Effektivnost’ dlitel’noi terapii ingibitorami kholinesterazy u bol’nykh dementsiei s tel’tsami Levi: Dis... kand. med. nauk. M. 2012. (In Russ.)
Nelson PT, Kryscio RJ, Jicha GA, Abner EL, Schmitt FA, Xu LO, Cooper G, Smith CD, Markesbery WR. Relative preservation of MMSE scores in autopsy-proven dementia with Lewy bodies. Neurology. 2009;73 (14):1127-1133. https://doi.org/10.1212/WNL.0b013e3181bacf9e
Rongve A, Soennesyn H, Skogseth R, Oesterhus R, Hortobágyi T, Ballard C, Auestad BH, Aarsland D. Cognitive decline in dementia with Lewy bodies: a 5-year prospective cohort study. BMJ Open. 2016;6(2):e010357. https://doi.org/10.1136/bmjopen-2015-010357
Irwin DJ, Grossman M, Weintraub D, Hurtig HI, Duda JE, Xie SX, Lee EB, Van Deerlin VM, Lopez OL, Kofler JK, Nelson PT, Jicha GA, Woltjer R, Quinn JF, Kaye J, Leverenz JB, Tsuang D, Longfellow K, Yearout D, Kukull W, Keene CD, Montine TJ, Zabetian CP, Trojanowski JQ. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. Lancet Neurol. 2017;16:55-65. https://doi.org/10.1016/S1474-4422(16)30291-5